For research use only. Not for therapeutic Use.
Camoteskimab (AVTX-007) is a fully human, high-affinity anti-IL-18 monoclonal antibody. Camoteskimab has the potential for the autoinflammatory diseases research, including adult-onset Still’s disease (AOSD)[1].
| Catalog Number | I042146 |
| CAS Number | 2492472-82-7 |
| Purity | ≥95% |
| Reference | [1]. Paola Galozzi, et al. Progress in Biological Therapies for Adult-Onset Still’s Disease. Biologics. 2022 Apr 21;16:21-34. |
